Keywords: Transderaml Prescription drugs, Market, Pain management, Greystone

Transdermal prescription pain products market forecast to exceed $9 billion by 2015

Article | 01 December 2010

As people live longer and advance in age, the incidence of several types of chronic and acute pain will increase ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in